Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites.

NASDAQ: VCEL

$65.76 0.97 (1.5%)
Day High: $66.5
Day Low: $64.7601
Volume: 512082
4:00 PM on
June 24, 2021
Copyright West LLC. Minimum 15 minutes delayed.

Company Presentation